Retrospective analysis of total direct medical costs associated with hepatitis B patients with oral antiviral versus pegylated interferon therapy in Turkey-Reference-Cited by-同舟云学术

Retrospective analysis of total direct medical costs associated with hepatitis B patients with oral antiviral versus pegylated interferon therapy in Turkey

Published:2014-02-18 Issue:11 Volume:21 Page:794-801
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Altinbas A.¹,Baser E.²,Burkan A.³,Ertugay E.³,Kariburyo M. F.⁴,Baser O.⁵

Affiliation:

1. Ankara Numune Education and Research Hospital; Gastroenterology Clinic; Ankara Turkey

2. STATinMED Research; Ankara Turkey

3. Social Security Institution; Ankara Turkey

4. STATinMED Research; Ann Arbor MI USA

5. The University of Michigan and STATinMED Research; Ann Arbor MI USA

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12206/fullpdf

Reference31 articles.

1. Hepatitis B: Fact Sheet No: 204 2012 http://www.who.int/mediacentre/factsheets/fs204/en/

2. Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B;Toy;Hepatology,2009

3. The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country;Toy;Eur J Health Econ,2012

4. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey;Gurol;Eur J Epidemiol,2006

5. Horizontal transmission of hepatitis B virus in Turkey;Degertekin;Public Health,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The creative destruction: the reason why the Turkish Gastroenterology community is ready for the new era: a mini-brainstorm to support the fast-growing and encouraging environment in Turkey;European Journal of Gastroenterology & Hepatology;2019-05

2. Hepatitis D virus infection in patients with hepatitis B virus occult infection;European Journal of Gastroenterology & Hepatology;2019-05

3. A quick overview to the early phase clinical trials of Simtuzumab®: Are we loosing the most promising anti-fibrotic product?;Medical Hypotheses;2017-10

4. Economic Impact and Complications of Treated and Untreated Hepatitis C Virus Patients in Turkey;Value in Health Regional Issues;2015-09

5. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy;Current Medical Research and Opinion;2014-09-29